They will likely want to: Review your complete medication list to identify potential interactions with other drugs you are taking Assess your diabetes status and current glycaemic control if you have type 2 diabetes Evaluate your tolerance of Wegovy to date, particularly regarding gastrointestinal side effects Discuss your treatment goals and whether berberine is likely to provide meaningful additional benefit Establish a monitoring plan if you proceed with the combination For people with type 2 diabetes and existing diabetic retinopathy, healthcare professionals may recommend appropriate eye monitoring when starting treatments that can rapidly improve glycaemic control, as this can sometimes temporarily worsen retinopathy
Patients with active cancer (any malignancy) must not use sermorelin, since increasing growth factors could potentially stimulate tumor growth
Data Extraction and Grading The data were extracted independently by the authors and were cross-checked by discussion among the 4 reviewers (M.A., A.A., B.A.K., S.T.S.), with guidance from the senior authors (S.N., N.A.) in case of discrepancy
DOI: 10.1210/en.2014-1675 [Google Scholar] Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al
Calendar reminders for reauthorization timing prevent gaps in medication coverage that can otherwise interrupt treatment and produce the regain biology documented in maintenance-phase research
